← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 14, 2018Last known activity
Aug 14, 2025
Timeline
2010s
- Jun 1, 2013
Alector Inc.— Founded
Drugs by trial phase (5 distinct, 12 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (13)
- NCT07105709CollaboratorPhase 2Aug 14, 2025
- NCT06111014Lead sponsorPhase 3Dec 8, 2023
- NCT06111014Study directorPhase 3Dec 8, 2023
- NCT06079190CollaboratorPhase 2Oct 11, 2023
- NCT05744401Lead sponsorPhase 2Jan 4, 2023
- NCT05053035Lead sponsorPhase 2Sep 2, 2021
- NCT04592874Lead sponsorPhase 2Nov 30, 2020
- NCT04374136Lead sponsorPhase 3Jul 30, 2020
- NCT04111666Lead sponsorPhase 1Dec 14, 2019
- NCT03987295Lead sponsorPhase 2Jul 1, 2019
- NCT03822208Lead sponsorPhase 1Mar 29, 2019
- NCT03635047Lead sponsorPhase 1Nov 30, 2018
- NCT03636204Lead sponsorPhase 1Sep 14, 2018
Details
- Founded
- San Francisco, CA, US Jun 1, 2013
- Last known activity
- Aug 14, 2025